Binggong Zhao
School Of Bioengineering & Key Laboratory Of Protein Modification And Disease
Dalian, China
Dalian, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
FMNL3 Promotes Migration and Invasion of Breast Cancer Cells via Inhibiting Rad23B-Induced Ubiquitination of Twist1.
Journal: Journal of cellular physiology
Published: June 10, 2024
USP13 promotes breast cancer metastasis through FBXL14-induced Twist1 ubiquitination.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: January 23, 2023
Cryptochrome 2 acetylation attenuates its antiproliferative effect in breast cancer.
Journal: Cell death & disease
Published: December 16, 2022
Author Correction: FBXL10 promotes EMT and metastasis of breast cancer cells via regulating the acetylation and transcriptional activity of SNAI1.
Journal: Cell death discovery
Published: December 05, 2022
Trend of disease burden and risk factors of breast cancer in developing countries and territories, from 1990 to 2019: Results from the Global Burden of Disease Study 2019.
Journal: Frontiers in public health
Published: October 24, 2022
KLF12 promotes the proliferation of breast cancer cells by reducing the transcription of p21 in a p53-dependent and p53-independent manner.
Journal: Cell death & disease
Published: August 13, 2022
MZF1 (Myeloid Zinc Finger 1) activates transcriptional activity of p53 and suppresses breast cancer cell proliferation via acetyltransferase PCAF (P300/CBP associated factor).
Journal: Genes & diseases
Published: August 05, 2022
FBXL10 promotes EMT and metastasis of breast cancer cells via regulating the acetylation and transcriptional activity of SNAI1.
Journal: Cell death discovery
Published: August 10, 2021
FBXL10 promotes ERRα protein stability and proliferation of breast cancer cells by enhancing the mono-ubiquitylation of ERRα.
Journal: Cancer letters
Published: October 06, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026